Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption.
We investigated whether therapeutic vaccination in highly active antiretroviral therapy (HAART)-treated patients with a modified vaccinia virus Ankara-vectored HIV-1 vaccine, with or without therapy interruption, induced the production of interleukin (IL)-10. Plasma IL-10 levels were not significant...
Autores principales: | Yang, H, Guimarães-Walker, A, Hibbs, S, Dong, T, Stacey, A, Borrow, P, Hanke, T, Davenport, M, McMichael, A, Dorrell, L |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2009
|
Ejemplares similares
-
Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
por: Touloumi, G, et al.
Publicado: (2006) -
TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
por: Angus, B, et al.
Publicado: (2008) -
Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
por: Dorrell, L, et al.
Publicado: (2005) -
Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
por: Mocroft, A, et al.
Publicado: (2009) -
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
por: Gondim, MVP, et al.
Publicado: (2021)